Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Over the last decade autologous stem cell transplantation (ASCT) has emerged as the standard of care in the management of Multiple Myeloma (MM). However, the cases of early relapse (within 36 months) after the stem cell rescue remains a significant challenge. For a lot of practical purposes, it is c...

Full description

Bibliographic Details
Main Authors: Chitrita Goswami, Sarita Poonia, Lalit Kumar, Debarka Sengupta
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
autologous stem cell transplantation
risk of relapse
multivariate survival analysis
spectral clustering
fast and frugal tree
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00633/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00633/full

Similar Items